MX2012002758A - Pirazinil-piridinas utiles para el tratamiento de enfermedades proliferativas. - Google Patents
Pirazinil-piridinas utiles para el tratamiento de enfermedades proliferativas.Info
- Publication number
- MX2012002758A MX2012002758A MX2012002758A MX2012002758A MX2012002758A MX 2012002758 A MX2012002758 A MX 2012002758A MX 2012002758 A MX2012002758 A MX 2012002758A MX 2012002758 A MX2012002758 A MX 2012002758A MX 2012002758 A MX2012002758 A MX 2012002758A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrazinylpyridines
- useful
- treatment
- proliferative diseases
- compound
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- IUEQMQXAVZARKU-UHFFFAOYSA-N 2-pyridin-2-ylpyrazine Chemical class N1=CC=CC=C1C1=CN=CC=N1 IUEQMQXAVZARKU-UHFFFAOYSA-N 0.000 title 1
- 230000002062 proliferating effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 abstract 1
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27593809P | 2009-09-04 | 2009-09-04 | |
| US28496209P | 2009-12-28 | 2009-12-28 | |
| PCT/EP2010/062881 WO2011026904A1 (en) | 2009-09-04 | 2010-09-02 | Pyrazinylpyridines useful for the treatment of proliferative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012002758A true MX2012002758A (es) | 2012-04-19 |
Family
ID=43480986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012002758A MX2012002758A (es) | 2009-09-04 | 2010-09-02 | Pirazinil-piridinas utiles para el tratamiento de enfermedades proliferativas. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20120165306A1 (OSRAM) |
| EP (1) | EP2473505A1 (OSRAM) |
| KR (1) | KR20120076352A (OSRAM) |
| CN (1) | CN102482265A (OSRAM) |
| AU (1) | AU2010291199A1 (OSRAM) |
| BR (1) | BR112012004836A2 (OSRAM) |
| CA (1) | CA2772265A1 (OSRAM) |
| IN (1) | IN2012DN01273A (OSRAM) |
| MX (1) | MX2012002758A (OSRAM) |
| WO (1) | WO2011026904A1 (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8415381B2 (en) * | 2009-07-30 | 2013-04-09 | Novartis Ag | Heteroaryl compounds and their uses |
| JP2014506878A (ja) * | 2011-01-28 | 2014-03-20 | ノバルティス アーゲー | Ｃｄｋ９阻害剤としての置換ビ−ヘテロアリール化合物およびそれらの使用 |
| WO2012101064A1 (en) * | 2011-01-28 | 2012-08-02 | Novartis Ag | N-acyl pyrimidine biaryl compounds as protein kinase inhibitors |
| WO2014106606A1 (en) * | 2013-01-05 | 2014-07-10 | F. Hoffmann-La Roche Ag | Nove phenyl/pyridine series substitued by hydroxyethylamino for the treatment of cancer |
| CA2923804A1 (en) | 2013-09-12 | 2015-03-19 | Sumitomo Chemical Company, Limited | Nitrogen-containing saturated heterocyclic compound |
| JO3589B1 (ar) | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
| EP3528812B1 (en) | 2016-10-20 | 2020-12-30 | Pfizer Inc | Palbociclib for treating pah |
| WO2020016579A2 (en) | 2018-07-17 | 2020-01-23 | Gtn Ltd | Machine learning based methods of analysing drug-like molecules |
| JP2023505850A (ja) * | 2019-12-09 | 2023-02-13 | 石薬集団中奇制薬技術（石家庄）有限公司 | サイクリン依存性キナーゼ９阻害剤としての化合物及びその用途 |
| GB202013419D0 (en) | 2020-08-27 | 2020-10-14 | Kuano Ltd | Transition state 2020 |
| CN115381824B (zh) * | 2021-05-24 | 2024-11-05 | 石药集团中奇制药技术（石家庄）有限公司 | 周期蛋白依赖性激酶9抑制剂的用途 |
| CN115381823B (zh) * | 2021-05-24 | 2024-11-05 | 石药集团中奇制药技术（石家庄）有限公司 | 一种周期蛋白依赖性激酶9抑制剂的用途 |
| WO2022257965A1 (zh) * | 2021-06-09 | 2022-12-15 | 石药集团中奇制药技术（石家庄）有限公司 | 固体形式的周期蛋白依赖性激酶9抑制剂及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT72878B (en) | 1980-04-24 | 1983-03-29 | Merck & Co Inc | Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents |
| AU9458401A (en) * | 2000-09-20 | 2002-04-02 | Ortho Mcneil Pharm Inc | Pyrazine derivatives as modulators of tyrosine kinases |
| CA2514733A1 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| WO2008079933A2 (en) * | 2006-12-22 | 2008-07-03 | Novartis Ag | Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections |
-
2010
- 2010-09-02 MX MX2012002758A patent/MX2012002758A/es not_active Application Discontinuation
- 2010-09-02 IN IN1273DEN2012 patent/IN2012DN01273A/en unknown
- 2010-09-02 WO PCT/EP2010/062881 patent/WO2011026904A1/en not_active Ceased
- 2010-09-02 EP EP10748097A patent/EP2473505A1/en not_active Withdrawn
- 2010-09-02 CA CA2772265A patent/CA2772265A1/en not_active Abandoned
- 2010-09-02 BR BR112012004836A patent/BR112012004836A2/pt not_active IP Right Cessation
- 2010-09-02 CN CN2010800392830A patent/CN102482265A/zh active Pending
- 2010-09-02 US US13/393,457 patent/US20120165306A1/en not_active Abandoned
- 2010-09-02 KR KR1020127008621A patent/KR20120076352A/ko not_active Withdrawn
- 2010-09-02 AU AU2010291199A patent/AU2010291199A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20120165306A1 (en) | 2012-06-28 |
| BR112012004836A2 (pt) | 2019-09-24 |
| KR20120076352A (ko) | 2012-07-09 |
| EP2473505A1 (en) | 2012-07-11 |
| CN102482265A (zh) | 2012-05-30 |
| AU2010291199A1 (en) | 2012-03-08 |
| WO2011026904A1 (en) | 2011-03-10 |
| CA2772265A1 (en) | 2011-03-10 |
| IN2012DN01273A (OSRAM) | 2015-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012002761A (es) | Bipiridinas utiles para el tratamiento de enfermedades proliferativas. | |
| IN2012DN01273A (OSRAM) | ||
| MX2012002752A (es) | Compuestos de heteroarilo como inhibidores de cinasa. | |
| WO2011123946A8 (en) | Kinase inhibitors and method of treating cancer with same | |
| JO2885B1 (en) | Protein kinase inhibitors | |
| JO2848B1 (en) | Organic compounds | |
| WO2012068096A3 (en) | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture | |
| WO2012068106A3 (en) | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture | |
| WO2010151710A3 (en) | Substituted heterocyclic compounds as kinases inhibitors and method of use thereof | |
| UA102251C2 (ru) | Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера | |
| PH12013502677A1 (en) | Benzylamine derivatives as inhibitors of plasma kallikrein | |
| MX2011011854A (es) | Dihidropirimidinonas para uso como inhibidores de la bace2. | |
| MX2011011335A (es) | Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina. | |
| MX2010008460A (es) | Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular. | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| MX346186B (es) | Inhibidores de proteina cinasas. | |
| MX2011009796A (es) | Inhibidores de la cinasa pi3. | |
| NZ599513A (en) | Compounds for the treatment of dyslipidemia and related diseases | |
| AU2011286276A8 (en) | Substituted Biphenylene Compounds and methods of use thereof for the treatment of viral diseases | |
| EA201490269A1 (ru) | Новое производное 1,2,3,4-тетрагидрохинолина, подходящее для лечения диабета | |
| MX2013002851A (es) | Inhibidores de tonum pectinacetilesterasa y metodos de su uso. | |
| CR20200286A (es) | DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294) | |
| MY169485A (en) | Heterocyclic compounds suitable for the treatment of dyslipidemia | |
| GEP20125708B (en) | Hydroxamate-based inhibitors of deacetylases b | |
| EA201200868A1 (ru) | Ингибиторы диацилглицеролацилтрансферазы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |